^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ewing Sarcoma |
| Drug: | temozolomide (DNA synthesis inhibitor) + irinotecan (Topoisomerase I inhibitor) + vincristine (Tubulin polymerization inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
11/20/2020
Excerpt:
Ewing sarcoma: Second-line therapy (relapsed/refractory or metastatic disease)…Preferred Regimens…Irinotecan + Temozolomide ± vincristine
